{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:34:35Z","timestamp":1787841275711,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sepsis-induced myocardial dysfunction (SIMD) is a severe consequence of systemic infection, primarily driven by mitochondrial dysfunction, inflammation, and pyroptosis. Sonlicromanol, a mitochondrial redox-modulating therapeutic agent, has shown promise in preserving mitochondrial function, but its role in sepsis-induced cardiac injury remains unclear. This study evaluates the protective effects of sonlicromanol in a rat model of sepsis-induced cardiac dysfunction, with a focus on mitochondrial dynamics, mitophagy, and inflammasome-pyroptosis pathways. Male Sprague\u2013Dawley rats were subjected to cecal ligation and puncture (CLP) to induce sepsis. Sonlicromanol (50 mg\/kg\/day) was administered intraperitoneally for 2 weeks before CLP. Rats were divided into five groups: (1) Control, (2) CLP, (3) CLP + sonlicromanol, (4) CLP + Mdivi-1 (mitophagy inhibitor), and (5) CLP + sonlicromanol + Mdivi-1. Cardiac function was evaluated via catheter-based pressure analysis, including left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), and left ventricular developed pressure (LVDP). Myocardial injury, histopathology, inflammasome-pyroptosis activation, mitophagy, and mitochondrial dynamics were assessed via enzyme-linked immunosorbent assay, H and E staining, Western blot, and mitochondrial fluorometric assays. CLP-induced septic rats showed reduced LVSP and LVDP, along with elevated LVEDP, cardiotroponin, and B-type natriuretic peptide, and significant myocardial damage. Pyroptosis markers (nucleotide-binding oligomerization domain-like receptor pyrin domain-containing protein 3, cleaved caspase-1, gasdermin-D, interleukin-1 \u03b2, and lactate-dehydrogenase) were elevated, while mitophagy markers (PTEN-induced kinase 1 and Parkin) and mitochondrial function (membrane potential and adenosine triphosphate levels) declined. Sonlicromanol significantly improved cardiac function and injury markers, suppressed pyroptosis, restored mitochondrial dynamics (increased mitofusin-2, modulated dynamin-related protein 1), enhanced mitophagy, and improved mitochondrial function. Mdivi-1 co-treatment attenuated these effects, indicating a role for mitochondrial dynamics and mitophagy in sonlicromanol\u2019s efficacy. Sonlicromanol ameliorates SIMD by modulating mitochondrial homeostasis and inhibiting pyroptosis. These findings support sonlicromanol as a potential therapy for sepsis-related cardiac injury.<\/jats:p>","DOI":"10.4103\/ejpi.ejpi-d-25-00033","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T11:00:08Z","timestamp":1758106808000},"page":"338-348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sonlicromanol Mitigates Sepsis-induced Heart Injury via Mitochondrial and Pyroptosis Modulation"],"prefix":"10.4103","volume":"68","author":[{"given":"Xinxin","family":"Qi","sequence":"first","affiliation":[{"name":"Department of Critical Care, Wuhan University of Science and Technology Affiliated Puren Hospital, Hubei, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Emergency, Huai\u2019an Clinical Medical College of Jiangsu University (Huai\u2019an Hospital of Huai\u2019an City), Huaian Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"R1-20251201","doi-asserted-by":"crossref","first-page":"ofy313","DOI":"10.1093\/ofid\/ofy313","article-title":"Sepsis in intensive care unit patients:Worldwide data from the intensive care over nations audit","volume":"5","author":"Sakr","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R2-20251201","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/jcm14030986","article-title":"Septic cardiomyopathy:Difficult definition, challenging diagnosis, unclear treatment","volume":"14","author":"Zakynthinos","year":"2025","journal-title":"J Clin Med"},{"key":"R3-20251201","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40635-025-00728-w","article-title":"Sepsis-induced cardiac dysfunction:Mitochondria and energy metabolism","volume":"13","author":"Yu","year":"2025","journal-title":"Intensive Care Med Exp"},{"key":"R4-20251201","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13054-024-05069-w","article-title":"Mitochondrial dysfunction in sepsis:Mechanisms and therapeutic perspectives","volume":"28","author":"Hu","year":"2024","journal-title":"Crit Care"},{"key":"R5-20251201","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5492\/wjccm.v12.i3.139","article-title":"Sepsis-induced mitochondrial dysfunction:A narrative review","volume":"12","author":"Nedel","year":"2023","journal-title":"World J Crit Care Med"},{"key":"R6-20251201","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J Immunol"},{"key":"R7-20251201","doi-asserted-by":"crossref","first-page":"101523","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol"},{"key":"R8-20251201","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/ars.2021.0145","article-title":"Mitochondrial fusion, fission, and mitophagy in cardiac diseases:Challenges and therapeutic opportunities","volume":"36","author":"Scheffer","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"R9-20251201","doi-asserted-by":"crossref","first-page":"116673","DOI":"10.1016\/j.biopha.2024.116673","article-title":"The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis:Therapeutic implications and animal model studies","volume":"175","author":"Shadab","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R10-20251201","doi-asserted-by":"crossref","first-page":"11733","DOI":"10.1038\/s41598-017-09417-5","article-title":"Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh disease","volume":"7","author":"de Haas","year":"2017","journal-title":"Sci Rep"},{"key":"R11-20251201","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10557-021-07189-9","article-title":"The redox modulating sonlicromanol active metabolite KH176m and the antioxidant MPG protect against short-duration cardiac ischemia-reperfusion injury","volume":"35","author":"Xiao","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"R12-20251201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cpt.1197","article-title":"The KHENERGY study:Safety and efficacy of KH176 in mitochondrial m 3243A>G spectrum disorders","volume":"105","author":"Janssen","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"R13-20251201","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1038\/s41598-018-24900-3","article-title":"KH176 safeguards mitochondrial diseased cells from redox stress-induced cell death by interacting with the thioredoxin system\/peroxiredoxin enzyme machinery","volume":"8","author":"Beyrath","year":"2018","journal-title":"Sci Rep"},{"key":"R14-20251201","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4149\/gpb_2023003","article-title":"Targeting AMPK\/eNOS pathway and mitochondria by sonlicromanol protects myocardial cells against ischemia-reperfusion injury","volume":"42","author":"Liao","year":"2023","journal-title":"Gen Physiol Biophys"},{"key":"R15-20251201","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.stemcr.2021.07.002","article-title":"Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m 3243A>G heteroplasmy in iPSC-derived neurons","volume":"16","author":"Klein Gunnewiek","year":"2021","journal-title":"Stem Cell Reports"},{"key":"R16-20251201","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/brain\/awae277","article-title":"Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m 3243A>G mutation","volume":"148","author":"Smeitink","year":"2025","journal-title":"Brain"},{"key":"R17-20251201","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12883-022-02685-3","article-title":"A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms (\u201cKHENERGYC\u201c)","volume":"22","author":"Smeitink","year":"2022","journal-title":"BMC Neurol"},{"key":"R18-20251201","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.3390\/ijms24119578","article-title":"Advances in rodent experimental models of sepsis","volume":"24","author":"Cai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R19-20251201","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/ALN.0b013e3181a1f720","article-title":"Simultaneous measurement of cardiac troponin I, B-type natriuretic peptide, and C-reactive protein for the prediction of long-term cardiac outcome after cardiac surgery","volume":"111","author":"Fellahi","year":"2009","journal-title":"Anesthesiology"},{"key":"R20-20251201","doi-asserted-by":"crossref","first-page":"1200441","DOI":"10.3389\/fcvm.2023.1200441","article-title":"Sepsis-induced myocardial dysfunction:Heterogeneity of functional effects and clinical significance","volume":"10","author":"Shvilkina","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R21-20251201","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"R22-20251201","doi-asserted-by":"crossref","first-page":"102968","DOI":"10.1016\/j.redox.2023.102968","article-title":"Restoring the infected powerhouse:Mitochondrial quality control in sepsis","volume":"68","author":"Lira Chavez","year":"2023","journal-title":"Redox Biol"},{"key":"R23-20251201","doi-asserted-by":"crossref","first-page":"664896","DOI":"10.3389\/fcell.2021.664896","article-title":"Mechanism of mitophagy and its role in sepsis induced organ dysfunction:A review","volume":"9","author":"Zhu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R24-20251201","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1083\/jcb.201612106","article-title":"Mitochondrial fission facilitates the selective mitophagy of protein aggregates","volume":"216","author":"Burman","year":"2017","journal-title":"J Cell Biol"},{"key":"R25-20251201","doi-asserted-by":"crossref","first-page":"115497","DOI":"10.1016\/j.biopha.2023.115497","article-title":"NLRP3 inflammasome involves in the pathophysiology of sepsis-induced myocardial dysfunction by multiple mechanisms","volume":"167","author":"Zhang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R26-20251201","doi-asserted-by":"crossref","first-page":"1063556","DOI":"10.3389\/fphys.2023.1063556","article-title":"Mitochondrial dysfunction in cardiovascular disease:Towards exercise regulation of mitochondrial function","volume":"14","author":"Li","year":"2023","journal-title":"Front Physiol"},{"key":"R27-20251201","doi-asserted-by":"crossref","first-page":"99","DOI":"10.14744\/cpr.2025.01903","article-title":"Sepsis:An overview of current therapies and future research","volume":"47","author":"Demir","year":"2025","journal-title":"J Clin Pract Res"},{"key":"R28-20251201","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1097\/MS9.0000000000002048","article-title":"Recent trends in septic shock management:A narrative review of current evidence and recommendations","volume":"86","author":"Nofal","year":"2024","journal-title":"Ann Med Surg (Lond)"}],"container-title":["Journal of Physiological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-25-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:48:08Z","timestamp":1787838488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-25-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ejpi.ejpi-d-25-00033","relation":{},"ISSN":["2950-6344","2950-6352"],"issn-type":[{"value":"2950-6344","type":"print"},{"value":"2950-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"assertion":[{"value":"2025-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}